Ubs Asset Management Americas Inc Igm Biosciences, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,164 shares of IGMS stock, worth $1,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,164Holding current value
$1,466% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding IGMS
# of Institutions
80Shares Held
15.8MCall Options Held
26.8KPut Options Held
800-
Baker Bros. Advisors LP New York, NY4.1MShares$5.16 Million0.06% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.1 Million0.21% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.72 Million0.36% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA876KShares$1.1 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $36.5M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...